TNF and cancer: The tumor necrosis factor-α (TNF-α) and soluble interleukin-2 receptor (SIL-2R) are targeted markers commonly used in the clinic to diagnose and treat malignancies, and the higher the expression levels of serum TNF-α and SIL-2R, the higher the stage of cancer, and vice versa.